Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
Part of paid clinical trials in Charlotte, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT06607406
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma HNSCC
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Accelerated radiotherapy — RADIATION6 fractions per week, BID fractions one day per week
- Conventional radiotherapy — RADIATION5 fractions per week, daily M-F
Study Details
The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.
Key Dates
- Start date
- Jan 21, 2025
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Conventional fractionation (5 Fractions)5 fractions per week, daily treatment Monday-Friday; dosage at the discretion of the treating radiation oncologist per standard of care
- Experimental: Accelerated fractionation (6 Fractions)6 fractions per week, daily treatment plus twice daily treatment for 1 day Monday-Friday; dosage at the discretion of the treating radiation oncologist per standard of care
Primary Outcome Measure
Locoregional Recurrence-free Survival [ Time Frame: 2 years post radiotherapy ]
Central Contacts
- Ryan Hughes, MD336-713-6575
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | |
| Advocate Aurora Radiation Oncology | Milwaukee | Wisconsin | 53215 |
Find similar trials in Charlotte, NC
By condition
Related Studies
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsPHASE1 · Recruiting · Memgen, Inc. · Tampa, Florida
- Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant TherapyRecruiting · Medical University of South Carolina · St Louis, Missouri